Prediction of human serum albumin-drug binding affinity without albumin

被引:26
作者
Hanai, T [1 ]
Koseki, A
Yoshikawa, R
Ueno, A
Kinoshita, T
Homma, H
机构
[1] Hlth Res Fdn, Inst Pasteur 5F, Sakyo Ku, Kyoto 606, Japan
[2] Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, Tokyo 108, Japan
关键词
prediction of binding affinity; human serum; albumin; drugs; chromatography;
D O I
10.1016/S0003-2670(01)01515-X
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A new liquid chromatographic system was developed to measure protein-drug binding affinity indirectly without albumin and was evaluated using log nK values of drugs measured by a modified Hummel-Dreyer method using purified human serum albumin. The retention factors of acidic and basic drugs were measured by reversed-phase and ion-exchange liquid chromatography in sodium phosphate buffer, pH 7.40, containing 50 vol.% methanol at 37 degreesC. The bonded phases were pentyl, guanidino and carboxyl phases. The combined retention factors were correlated with the log nK values measured by a modified Hummel-Dreyer method because glycosylation of human serum albumin did not significantly affect log nK value. The correlation coefficients were 0.949 (n = 7) for acidic drugs and 0.978 (n = 5) for basic drugs. The log nK values of 26 acidic and 18 basic drugs were predicted from their retention factors measured by reversed-phase and ion-exchange liquid chromatography. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:101 / 108
页数:8
相关论文
共 32 条
[1]  
Benet L.Z., 1984, PHARMACOKINETIC BASI, P12
[2]   NONENZYMATIC GLYCOSYLATION AND THE PATHOGENESIS OF DIABETIC COMPLICATIONS [J].
BROWNLEE, M ;
VLASSARA, H ;
CERAMI, A .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (04) :527-537
[3]  
CHANG JCF, 1985, J BIOL CHEM, V260, P7970
[4]  
Cserhati T., 1993, CHROMATOGRAPHIC DETE, P173
[5]   NOVEL PYRROLES FROM SULFITE-INHIBITED MAILLARD REACTIONS - INSIGHT INTO THE MECHANISM OF INHIBITION [J].
FARMAR, JG ;
ULRICH, PC ;
CERAMI, A .
JOURNAL OF ORGANIC CHEMISTRY, 1988, 53 (10) :2346-2349
[6]   THE LOCATION OF DRUG-BINDING SITES IN HUMAN-SERUM ALBUMIN [J].
FEHSKE, KJ ;
MULLER, WE ;
WOLLERT, U .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (07) :687-692
[7]   CHARACTERIZATION OF THE PROTEIN-BINDING OF CHIRAL DRUGS BY HIGH-PERFORMANCE AFFINITY-CHROMATOGRAPHY - INTERACTIONS OF R-IBUPROFEN AND S-IBUPROFEN WITH HUMAN SERUM-ALBUMIN [J].
HAGE, DS ;
NOCTOR, TAG ;
WAINER, IW .
JOURNAL OF CHROMATOGRAPHY A, 1995, 693 (01) :23-32
[8]  
Hanai T, 1998, J CHROMATOGR LIBR, V60, P1, DOI 10.1016/S0301-4770(08)60295-X
[9]   Quantitative analysis of human serum albumin drug interactions using reversed-phase and ion-exchange liquid chromatography [J].
Hanai, T ;
Miyazaki, R ;
Kinoshita, T .
ANALYTICA CHIMICA ACTA, 1999, 378 (1-3) :77-82
[10]  
HANNI T, 2000, ADV CHROMATOGR, V40, P315